Taro-Sunitinib 50 mg

TARO-SUNITINIB 50 MG capsules are a pharmaceutical product containing Sunitinib Malate, used for targeted therapy. This oral medication is designed to support specific treatment protocols as prescribed by healthcare professionals.

TARO-SUNITINIB 50 MG capsules are primarily used in targeted therapy for certain types of cancer. Sunitinib Malate, the active ingredient, is often prescribed to interfere with the growth and spread of cancer cells. Patients may wonder, 'What is Sunitinib used for?' This medication is typically part of a broader treatment plan aimed at managing specific conditions.

Common effects of TARO-SUNITINIB 50 MG capsules may include fatigue, nausea, and diarrhea. Some users might experience changes in taste or skin discoloration. These effects can vary widely among individuals and are not exhaustive. Always consult a healthcare provider for personalized advice.

TARO-SUNITINIB 50 MG capsules should be handled with care. Store the medication in a cool, dry place away from direct sunlight. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Do not share this medication with others.

TARO-SUNITINIB 50 MG capsules may interact with certain medications, including those metabolized by the liver's CYP3A4 enzyme. Alcohol consumption should be avoided as it may exacerbate side effects. Always inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.